Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Retatrutide (also known as LY3437943) is an investigational medicine being studied for obesity and metabolic disease
In terms of molecule class, semaglutide segment is set to command 58.0% share in the obesity GLP-1 market in 2025
It transforms a vague complaint of "I feel anxious" into actionable clinical information
Some people do well at 1.7 mg weekly, while others benefit from reaching the full 2.4 mg dose
A vial labeled 1 mg/mL contains 1 milligram in every milliliter of solution
With GLP1 medications like Wegovy or Zepbound, patients often lose 1522% of their body weight over timeand more importantly, they keep it off with long-term medical support
US$ 27.57
US$ 24.57
US$ 25.76
US$ 22.11
US$ 21.43
US$ 24.65
